[PHARMA] QoQ Quarter Result on 30-Jun-2015 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- -48.99%
YoY- 1.51%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 559,195 680,150 524,413 512,845 471,904 627,103 502,086 7.43%
PBT 26,538 23,717 25,337 25,056 38,612 37,854 24,945 4.20%
Tax -8,068 -7,676 -5,362 -8,414 -6,686 -1,233 -9,944 -12.99%
NP 18,470 16,041 19,975 16,642 31,926 36,621 15,001 14.86%
-
NP to SH 18,379 16,062 19,971 16,217 31,794 36,697 14,955 14.71%
-
Tax Rate 30.40% 32.36% 21.16% 33.58% 17.32% 3.26% 39.86% -
Total Cost 540,725 664,109 504,438 496,203 439,978 590,482 487,085 7.20%
-
Net Worth 515,906 529,786 534,373 528,477 528,173 525,351 507,124 1.15%
Dividend
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Div 10,354 18,134 23,312 18,134 18,123 31,055 20,698 -36.95%
Div Payout % 56.34% 112.90% 116.73% 111.82% 57.00% 84.63% 138.41% -
Equity
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Net Worth 515,906 529,786 534,373 528,477 528,173 525,351 507,124 1.15%
NOSH 258,859 259,064 259,027 259,057 258,908 258,794 258,737 0.03%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 3.30% 2.36% 3.81% 3.25% 6.77% 5.84% 2.99% -
ROE 3.56% 3.03% 3.74% 3.07% 6.02% 6.99% 2.95% -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 216.02 262.54 202.45 197.97 182.27 242.32 194.05 7.40%
EPS 7.10 6.20 7.71 6.26 12.28 14.18 5.78 14.68%
DPS 4.00 7.00 9.00 7.00 7.00 12.00 8.00 -36.97%
NAPS 1.993 2.045 2.063 2.04 2.04 2.03 1.96 1.11%
Adjusted Per Share Value based on latest NOSH - 259,057
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 38.80 47.19 36.39 35.58 32.74 43.51 34.84 7.43%
EPS 1.28 1.11 1.39 1.13 2.21 2.55 1.04 14.83%
DPS 0.72 1.26 1.62 1.26 1.26 2.15 1.44 -36.97%
NAPS 0.358 0.3676 0.3708 0.3667 0.3665 0.3645 0.3519 1.15%
Price Multiplier on Financial Quarter End Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 -
Price 5.76 6.36 6.50 7.13 6.00 4.58 4.63 -
P/RPS 2.67 2.42 3.21 3.60 3.29 1.89 2.39 7.65%
P/EPS 81.13 102.58 84.31 113.90 48.86 32.30 80.10 0.85%
EY 1.23 0.97 1.19 0.88 2.05 3.10 1.25 -1.06%
DY 0.69 1.10 1.38 0.98 1.17 2.62 1.73 -45.78%
P/NAPS 2.89 3.11 3.15 3.50 2.94 2.26 2.36 14.44%
Price Multiplier on Announcement Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 13/05/16 15/02/16 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 -
Price 5.60 6.19 6.50 5.65 6.91 5.28 4.45 -
P/RPS 2.59 2.36 3.21 2.85 3.79 2.18 2.29 8.54%
P/EPS 78.87 99.84 84.31 90.26 56.27 37.24 76.99 1.61%
EY 1.27 1.00 1.19 1.11 1.78 2.69 1.30 -1.54%
DY 0.71 1.13 1.38 1.24 1.01 2.27 1.80 -46.18%
P/NAPS 2.81 3.03 3.15 2.77 3.39 2.60 2.27 15.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment